ArticleOncoimmunology2016

Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer.

Dallas B Flies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.